Endo CEO Reveals Glimpse Of New Strategy: Highlights Generics Potential
This article was originally published in The Pink Sheet Daily
Executive Summary
During Endo’s first quarter sales and earnings call, new CEO Rajiv De Silva said his strategic review of the specialty pharma is still underway but offered investors some initial thoughts on his plans for the company.